VTYX•benzinga•
Ventyx Announces Phase 2 Trials For VTX2735, VTX3232; Obesity Data Expected H2 2025, Parkinson's Data H1 2025; $252.9M Funding Extends To H2 2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 14, 2025 by benzinga